Testing a new Strep A vaccine in healthy young adults
Part of Infections clinical trials.
This study tests a new vaccine designed to protect against Group A Strep bacteria. It will check how safe the vaccine is and how well it boosts your immune system. Healthy young adults between 18 and 25 years old may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 25 years old.
- You are generally healthy with no major medical conditions.
- You have not had strep throat in the last 4 weeks.
- You agree to use effective birth control if needed (or are not able to become pregnant).
- You are not pregnant, breastfeeding, or planning to become pregnant soon.
- You have not had a previous Strep A vaccine or any investigational vaccine in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new vaccine called VAX-A1 in healthy people aged 18–40 to see if it's safe and if it helps the body build protection against Group A Streptococcus (a bacteria that can cause serious infections). You'll receive two vaccine doses and have blood tests and heart monitoring over 6 months.
This study tests whether a new antibody treatment can safely stop strep throat infections. Healthy adults aged 18-40 will receive the antibody and then be exposed to the strep bacteria in a controlled setting to see if it protects them.
This study tests a new vaccine called StreptInCor that may help prevent rheumatic fever (a condition caused by strep infections that can damage the heart). It is an early trial to check if the vaccine is safe and produces a good immune response in healthy adults.
This study tests a new flu vaccine to see how well it helps the body fight off the flu. It is for generally healthy adults aged 18 to 59 who have not had the flu recently.
This study looks at children ages 5–15 who test positive for Group A strep (often called strep throat). It may help by testing an antibiotic approach with beta-lactam medicines for children who are expected to need treatment.
This study tests an experimental vaccine designed to protect against E. coli bacteria. It is for healthy adults aged 18 to 63 who want to help researchers see if the vaccine is safe and produces an immune response.
Hear when a new Streptococcal Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.